You Can't Run AI
On a PDF.
AI is only as good as the data it can access. Krevyos structures your pharmaceutical data so models can actually work with it.
Why AI-ready data matters
of pharma data is unstructured
Trapped in PDFs, spreadsheets, and disconnected systems. AI can't access it.
AI models run on documents
Every meaningful AI application requires structured, typed, relationship-rich data.
companies to structure win
The pharma companies that structure their data first will unlock AI capabilities years ahead of competitors.
AI Capabilities
Structure your data first. The AI capabilities follow.
AI models need structured, clean, typed data. Krevyos transforms your pharmaceutical knowledge from unstructured documents into a queryable, relationship-rich data model that ML systems can consume directly.
Leverage historical batch data, stability trends, and process parameters to predict outcomes before they happen. Identify potential issues in formulation stability or manufacturing variability early.
Automatically flag deviations from expected patterns across your data: unexpected stability trends, process parameter drift, or specification excursions. Catch problems at the data level, not the document level.
Use AI to identify gaps in your regulatory data package, suggest optimal study designs, and prioritize activities based on regulatory risk. Intelligence layered on structured data.
What Changes
- No separate data engineering project—AI readiness is built into the platform
- Historical data becomes queryable and analyzable the moment it's structured
- Predictive models trained on your own data, not generic pharmaceutical benchmarks
- Every AI-generated insight is traceable to its source data for regulatory defensibility
- Progressive AI adoption: start with analytics, graduate to prediction and optimization
Structure First. AI Follows.
Let us show you how structured data unlocks AI capabilities for your pharmaceutical workflows.
Start a Conversation